Chirag Kapadia
Pediatric Endocrinology · Phoenix, AZNPI 1518175991
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $7,977 of the $13,169 with a category attached, or 60.6%. 37 manufacturers reported payments, led by Novo Nordisk at 36.5% of the total. 2025 is the largest year on record at $5,069, more than ten times the $447 reported in 2019. Among pediatric endocrinology clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 183 payments — averaging $71.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$5K
- Eton Pharmaceuticals, Inc.$3K
- AstraZeneca$990
- Abbott$559
- Incyte Corporation$460
- Medtronic$400
- plus $3K from 31 others
What the payments were for
- Consulting fees$7,97761%
- Speaking & faculty fees$1101%
- Food & beverage$4,20432%
- Education$6305%
- Other$2502%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 13 | $4,801 |
| Eton Pharmaceuticals, Inc. | 4 | $2,562 |
| AstraZeneca(2 entities) | 2 | $990 |
| Abbott | 10 | $559 |
| Incyte Corporation | 9 | $460 |
| Medtronic(2 entities) | 13 | $400 |
| Ipsen Biopharmaceuticals, Inc | 5 | $391 |
| Pfizer | 22 | $367 |
| AbbVie | 12 | $343 |
| Sanofi-aventis U.S. LLC | 7 | $269 |
| Ascendis Pharma Endocrinology Inc | 7 | $248 |
| Insulet Corporation | 11 | $199 |
| Xeris Pharmaceuticals, Inc. | 5 | $196 |
| Arbor Pharmaceuticals, Inc. | 9 | $194 |
| Tandem Diabetes Care, Inc. | 2 | $149 |
| Lilly USA, LLC | 9 | $128 |
| Dexcom, Inc. | 6 | $114 |
| Rhythm Pharmaceuticals, Inc. | 6 | $108 |
| Ultragenyx Pharmaceutical Inc. | 3 | $83 |
| Ascensia Diabetes Care US Inc. | 4 | $64 |
| Tolmar, Inc. | 3 | $57 |
| Sanofi | 2 | $55 |
| Neurocrine Biosciences, Inc. | 2 | $50 |
| Intuity Medical Inc | 2 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| Tolmar Pharmaceuticals, Inc. | 2 | $43 |
| Blueprint Medicines Corporation | 1 | $32 |
| Soleno Therapeutics, Inc. | 1 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Johnson & Johnson | 1 | $25 |
| Geron Corporation | 1 | $23 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
| Tempus AI, Inc | 1 | $20 |
| Bayer | 1 | $20 |
| Zealand Pharma US, Inc. | 1 | $19 |
| Morphosys, US Inc. | 1 | $16 |
| AVEO Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Alkindi$2,547
- KHINDIVI$1,030
- INCRELEX$1,030
- Strensiq$900
- ONIVYDE$256
- FreeStyle Lite system$250
- Minimed 670G System$134
- t:slim X2 insulin pump$128
- Sogroya$123
- GVOKE HYPOPEN$122
- MONJUVI$110
How this compares
$13,169 in reported general payments places this provider in the 90th percentile of 35 pediatric endocrinology providers in Arizona.
Other pediatric endocrinology in Phoenix
- Eileen Baez IrizarryPhoenix$53K
- Pamela SmithPhoenix$26K
- Grazyna Piekos-SobczakPhoenix$12K
- Rola SaadPhoenix$10K
- Micah OlsonPhoenix$9K
- Rochelle WilsonPhoenix$4K
- Amanda CamposPhoenix$3K
- Mahmoud KabbaniPhoenix$3K
- Melissa ChambersPhoenix$3K
- Dorothee NewbernPhoenix$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.